Sierra Oncology
San Mateo
About Sierra Oncology
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $494.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2022)
- Ticker: nasdaq:SRRA
- Website: sierraoncology.com
- Phone: (604)558-6536
Industries & Categories
Biotechnology, Health Care, Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sierra-oncology-126460 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.